1. Tumors and metastases
- Suitable for patients who have been denied other forms of treatment.
- When the disease progresses and the main treatment is not effective enough.
- At all stages of cancer, including extensive metastatic disease.
OncoCareClinic 308
International clinic
for cancer treatment
Exclusive to our clinic
Cytokinogenetic
therapy (CGT)
Patented method
Personalized treatment plans
Used at all stages of the disease
Outpatient treatment
When is Cytokinogenetic therapy used?
2. Chemotherapy
- Alongside all chemotherapy regimens and other treatments: immunotherapy, radiation therapy, targeted therapy, and hormone therapy.
- We increase the effectiveness of chemotherapy and reduce its side effects.
3. Prevention
- To prevent recurrence, for people with a hereditary predisposition to cancer, and for those over 65.
About CGT
Cytokinogenetic therapy (CGT) is a modern cancer treatment method in the field of immuno-oncology.
The method aims to activate the body’s own defense mechanisms and enhance its immune response against tumors.
The goals of CGT are:
- Tumor shrinkage;
- Regression of metastases;
- Disease control;
- Prevention of recurrence.
Immune activation
We activate the body’s defenses to fight the tumor.
An individualized approach
We tailor the treatment regimen to each patient’s individual needs.
Supporting quality of life
To improve overall health and help patients stay active.
Treatment results for different types of stage 3–4 cancer
Treatment results
Lung cancer
Treatment response, %
Stable disease 59%
Partial response 25%
Complete response 6%
Stable disease (SD) means no changes and no new lesions. Stable disease is considered a positive treatment outcome because it halts tumor growth and improves quality of life.
Complete response (CR / regression) means the disappearance of all tumor lesions.
Partial response (PR) means a reduction of at least 30% in the sum of the diameters of the lesions.
Treatment outcomes vary from person to person and depend on the complexity of the diagnosis and the clinical situation.
Who is CGT suitable for?
- Patients with cancer at any stage
- Patients undergoing chemotherapy or other treatment
- Patients who have completed their main treatment
- Patients receiving palliative care
- Patients in remission
- People with a predisposition to cancer (hereditary predisposition, genetic mutations, oncogenic HPV strains, or benign tumors).
- People over 65
Compatible with all types of treatment
A comprehensive approach
Combining cytokinogenetic therapy with other types of treatment produces more effective results.
- Chemotherapy
- Immunotherapy
- Radiation therapy
- Targeted therapy
- Hormone therapy
- Also used as a standalone treatment
What is your current situation?
Cytokinogenetic therapy is not prescribed in the same way for everyone. Before treatment begins, an oncologist reviews the diagnosis, disease stage, previous treatment, test results, and the patient’s current condition.
If you are undergoing chemotherapy
Chemotherapy may cause weakness, loss of appetite, and a decline in well-being, along with concerns about being able to continue with the next cycle.
During your consultation, an OncoCareClinic308 doctor will review your treatment regimen, test results, and condition to determine whether cytokinogenetic therapy may be considered as additional support alongside your main treatment.
The aim of the consultation: To understand whether CGT is indicated and how it can be combined with your current treatment.
If the cancer has metastasized or progressed
When the disease continues to progress, patients and their families need to understand what additional medical support options may be considered alongside the main treatment.
The doctor will review your medical records, treatment history, and examination results to determine whether cytokinogenetic therapy may be appropriate in your situation.
The aim of the consultation: To obtain a medical opinion on whether CGT may be an option for advanced cancer.
After surgery or your main treatment
After surgery, chemotherapy, radiation therapy, or other treatment, many patients still have one main concern: the risk of recurrence.
During the consultation, the doctor will review your medical history, examination results, and current condition to discuss options for follow-up care and support aimed at preventing recurrence.
The aim of the consultation: To understand what steps can be taken after completing your main treatment.
If the patient is seriously ill or receiving palliative care
In palliative care, quality of life, symptom control, maintaining strength, and regular contact with a doctor are especially important.
An OncoCareClinic308 specialist will review the patient’s condition, current prescriptions, and medical records to determine whether cytokinogenetic therapy can be used as part of their medical care.
The aim of the consultation: To discuss whether it is possible to improve quality of life and support the patient at this stage.
Treatment steps
1
Call us or submit a request online
Our clinic administrators will arrange a convenient time for your consultation.
Consultations take place ONLINE via telemedicine or IN PERSON at our clinic at 4A Fadeeva Street, Moscow.
2
Prepare your documents
Please provide the following for your consultation:
- Oncologist’s reports confirming the diagnosis
- Recent test results
3
Your oncology consultation: what does it include?
- Taking your medical history
- Assessing your condition
- Reviewing your medical records
- Prescribing an individualized course of cytokinogenetic therapy
The doctor will answer all your questions about treatment in detail and outline a clear plan for the next steps.
4
Treatment and ongoing support
- When treatment is indicated, a program is developed with ongoing monitoring of progress.
- Detailed guidance on administering the medications is provided. Patients in other cities receive detailed instructions and video materials.
- We stay in touch. You can ask your treating doctor questions free of charge during the clinic’s opening hours.
Contraindications
This method is not used for:
- cancers of the blood-forming system
(leukemia, lymphoma, multiple myeloma) - thyroid tumors
Still have questions?
Request a call, and our coordinator will contact you to answer your questions about CGT in detail.
Your case is reviewed by doctors and oncology experts
The doctor assesses your diagnosis, previous treatment, examination results, and possible next steps.
Andrey Leonidovich Ilyushin
Chief Physician 22 years of experience
Candidate of Medical Sciences, oncologist
Book an appointmentAleksan Zavenovich Aleksanyan
Oncologist 49 years of experience
Professor, Doctor of Medical Sciences, highest qualification category, oncologist, radiologist, surgeon
Book an appointmentMohamed Amir Ben Ammar
Deputy Chief Physician 15 years of experience
Oncologist, immunologist, ultrasound specialist, laser surgeon, breast specialist, surgeon
Book an appointmentVladimir Tamazievich Zarkua
Oncologist 7 years of experience
Oncologist, urologist, andrologist, ultrasound specialist
Book an appointmentSafiya Vakhaevna Umarova
Oncologist 8 years of experience
Oncologist, obstetrician-gynecologist
Book an appointmentElena Eduardovna Spirochkina
Oncologist 10 years of experience
Oncologist, general practitioner
Book an appointmentLevon Andreevich Ashrafyan
Oncologist 45 years of experience
Academician of the Russian Academy of Sciences, Professor, Doctor of Medical Sciences, Honored Physician of the Russian Federation, gynecologic oncologist, obstetrician-gynecologist
Book an appointmentSvetlana Ivanovna Erofeeva
Oncologist, OKD No. 1 36 years of experience
Oncologist, chemotherapy specialist
Book an appointmentVeronika Nikolaevna Zadeya
Oncologist, P. A. Herzen Moscow Oncology Research Institute 42 years of experience
Candidate of Medical Sciences, oncologist
Book an appointmentAnna Valerevna Alyasova
Oncologist 36 years of experience
Professor, Doctor of Medical Sciences, oncologist
Book an appointmentNatalya Gennadyevna Sivakova
Oncologist, N. N. Blokhin National Medical Research Center of Oncology 18 years of experience
Candidate of Medical Sciences, oncologist
Book an appointmentThe standard treatment program includes 6 treatment cycles.
After the main phase is complete, the doctor assesses the treatment results using follow-up examinations (CT scans, MRI scans, and other tests) and determines the next steps.
Once the disease has stabilized, the patient may be switched to maintenance therapy, which usually involves one injection per month.
The duration of treatment is always determined individually and depends on the diagnosis, disease stage, response to therapy, and the patient’s overall condition.
Each cycle lasts 30 days:
- the first 20 days: daily injections;
- the next 10 days: a break.
The next treatment cycle then begins.
The treatment regimen, dosages, and program duration are selected by the doctor individually for each patient.
The medications are injected under the skin using a fine insulin needle in the abdomen, thigh, or upper arm.
Most patients successfully administer the injections themselves at home.
We provide:
- detailed video instructions;
- step-by-step written instructions;
- guidance and support from the clinic’s specialists.
Patients who live in Moscow can also have their injections administered in our clinic’s treatment room.
Including new treatment methods in the mandatory health insurance system is a lengthy process that can take many years.
We continue to work toward this goal and are committed to making modern treatments more accessible to patients.
Remote care was developed primarily for patients’ convenience and safety.
Many cancer patients undergo treatment with weakened immunity, so frequent travel and visits to medical facilities can place additional strain on the body.
Cytokinogenetic therapy does not require a continuous stay at the clinic and can be administered on an outpatient basis under medical supervision.
It is important to understand that a medication’s effectiveness does not depend on where it is administered. The same principle has long been used in modern oncology: many patients receive targeted therapy or anticancer medications in tablet form and take them at home.
Our specialists remain in contact and support the patient throughout every stage of treatment.
OncoCareClinic 308 works with patients throughout Russia and abroad.
We have deliberately chosen to operate as a single specialist center providing remote patient support. This allows us to:
- maintain consistent treatment standards;
- ensure strict quality control of medications;
- comply with storage and transportation requirements;
- maintain a high standard of medical support regardless of where the patient lives.
This enables patients to receive consultations and treatment from any city in Russia or elsewhere in the world.
